Trademark: 97477638
Word
GADRELON
Status
Pending
Status Code
731
Status Date
Thursday, March 21, 2024
Serial Number
97477638
Mark Type
4000
Filing Date
Monday, June 27, 2022
Published for Opposition
Tuesday, January 31, 2023

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Mar 22, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 21, 2024
Sou Extension 2 Granted
Mar 21, 2024
Sou Extension 2 Filed
Mar 21, 2024
Sou Teas Extension Received
Sep 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 19, 2023
Sou Extension 1 Granted
Sep 19, 2023
Sou Extension 1 Filed
Sep 19, 2023
Sou Teas Extension Received
Mar 28, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 31, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 31, 2023
Published For Opposition
Jan 11, 2023
Notification Of Notice Of Publication E-Mailed
Dec 28, 2022
Approved For Pub - Principal Register
Dec 27, 2022
Assigned To Examiner
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 14, 2022
New Application Office Supplied Data Entered
Jun 30, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24